Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Acella Pharmaceuticals, LLC

NDC labeler code: 42192

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

9Products (NDC)

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
April 19, 2022ANDA212405 Pyridostigmine bromide
PYRIDOSTIGMINE BROMIDE
Milla Pharms
March 16, 2020ANDA210664 Doxycycline
DOXYCYCLINE HYCLATE
Acella
September 18, 2019NDA208193 Baclofen
OZOBAX, OZOBAX DS
Rosemont
September 20, 2016ANDA203375 Brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide
BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE
Acella
May 1, 2012ANDA076403 Gabapentin
GABAPENTIN
Acella Pharms LLC
September 18, 2007ANDA078172 Ciclopirox
CICLOPIROX
Acella
September 13, 2006ANDA040573 Phenytoin
PHENYTOIN SODIUM
Acella
March 23, 1987NDA018965 Naproxen
NAPROSYN
Atnahs Pharma Us

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2026

  1. April 20, 2026 · Class II · Ongoing · D-0523-2026 · Naproxen

    Chemical contamination; presence of lead and lithium above specification

    NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16

2025

  1. September 29, 2025 · Class II · Ongoing · D-0014-2026 · Doxycycline

    Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

    Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.

2022

  1. November 14, 2022 · Class III · Terminated · D-0070-2023 · Phenytoin

    Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

    Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

  2. November 14, 2022 · Class III · Terminated · D-0069-2023 · Phenytoin

    Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

    Phenytoin Sodium Injection, USP 100 mg/2 mL, NDC 42192-614-02, packaged in 10 x 2 mL vials per carton, NDC 42192-614-10, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →